RICHLAND, Wash.--(BUSINESS WIRE)--April 18, 2006--IsoRay Medical, Inc. (OTCBB:ISRY - News), the world's only manufacturer and distributor of Cesium-131 used in the treatment of prostate cancer and other malignant diseases, has named Jonathan R. Hunt corporate controller.
